Neoleukin Therapeutics Inc (NAS:NLTX)
$ 3.49 0 (0%) Market Cap: 8.20 Mil Enterprise Value: -35.02 Mil PE Ratio: 0 PB Ratio: 0.10 GF Score: 22/100

Q3 2020 Capricor Therapeutics Inc Earnings Call Transcript

Nov 12, 2020 / 09:30PM GMT
Release Date Price: $250 (+5.13%)
Operator

Greetings, and welcome to the Capricor Therapeutics, Inc. Third Quarter 2020 Earnings Call. (Operator Instructions) As a reminder, this conference is being recorded.

It is now my pleasure to introduce your host, CFO, A.J. Bergmann. Thank you. You may begin.

Anthony J. Bergmann
Capricor Therapeutics, Inc. - CFO & Corporate Treasurer

Thank you. Before we start, I would like to state that we will be making certain forward-looking statements during today's presentation. These statements may include statements regarding, among other things, the efficacy, safety and intended utilization of our product candidates, our future research and development plans, including our anticipated conduct and timing of preclinical and clinical studies, our plans to present or report additional data, our plans regarding regulatory filings, potential regulatory developments involving our product candidates and our possible uses of existing cash and investment resources. These forward-looking statements are based on current information, assumptions and expectations that

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot